Connecting you to content on EBSCOhost

Works by Frostvik Stolt, Marianne

Results: 5

1

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma.

Published in:

2017

By:

Falkenius, Johan;
Johansson, Hemming;
Tuominen, Rainer;
Stolt, Marianne Frostvik;
Hansson, Johan;
Brage, Suzanne Egyhazi;
Frostvik Stolt, Marianne;
Egyhazi Brage, Suzanne

Publication type:

journal article

2

PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89389-9

By:

Vidarsdottir, Linda;
Azimi, Alireza;
Das, Ishani;
Sigvaldadottir, Ingibjorg;
Suryo Rahmanto, Aldwin;
Petri, Andreas;
Kauppinen, Sakari;
Ingvar, Christian;
Jönsson, Göran;
Olsson, Håkan;
Frostvik Stolt, Marianne;
Tuominen, Rainer;
Sangfelt, Olle;
Pokrovskaja Tamm, Katja;
Hansson, Johan;
Grandér, Dan;
Egyházi Brage, Suzanne;
Johnsson, Per

Publication type:

Article

3

Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 7, p. 1085, doi. 10.1007/s00262-008-0631-1

By:

Johansso, C. Christian;
Egyházi, Suzanne;
Masucci, Giuseppe;
Harlin, Helena;
Mougiakakos, Dimitrios;
Poschke, Isabel;
Nilsson, Bo;
Garberg, Liss;
Tuominen, Rainer;
Linden, Diana;
Stolt, Marianne Frostvik;
Hansson, Johan;
Kiessling, Rolf

Publication type:

Article

4

Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer.

Published in:

BMC Clinical Pathology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1472-6890-13-30

By:

Hjerpe, Elisabet;
Egyhazi Brage, Suzanne;
Carlson, Joseph;
Frostvik Stolt, Marianne;
Schedvins, Kjell;
Johansson, Hemming;
Shoshan, Maria;
Åvall-Lundqvist, Elisabeth

Publication type:

Article

5

MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma.

Published in:

International Journal of Cancer, 2015, v. 136, n. 12, p. 2844, doi. 10.1002/ijc.29332

By:

Tuominen, Rainer;
Jewell, Rosalyn;
van den Oord, Joost J.;
Wolter, Pascal;
Stierner, Ulrika;
Lindholm, Christer;
Hertzman Johansson, Carolina;
Lindén, Diana;
Johansson, Hemming;
Frostvik Stolt, Marianne;
Walker, Christy;
Snowden, Helen;
Newton‐Bishop, Julia;
Hansson, Johan;
Egyházi Brage, Suzanne

Publication type:

Article